Breaking Down the Bonkers 'Run Away' Ending Involving Cults, Estranged Siblings, and More Surprise Twists

Among the names on their hit list is Aaron Corval, who Paige discovers is Ingrid's biological son. As Paige reveals to her ...
Hosted on MSN

No one can break out of these countries

Securing a border is often a top priority for national security. Yet sometimes these borders are so secure, they are just as effective at keeping people out, as they are at keeping people in. Today we ...
Seeking Alpha

Recursion Pharmaceuticals: Artificial Intelligence, Real Disappointment

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
Benzinga.com

Why Are Shares Of Recursion Pharmaceuticals Higher Today?

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
AOL

A Trio of No-Nonsense Nuns Break Out of Nursing Room and Return to Convent That Evicted Them

It was dubbed “Operation Get Thee to the Nunnery.” Sisters Rita, Regina and Bernadette recently escaped from a nursing home in Elsbethen, Austria. They then broke into the convent that had evicted ...
The New York Times

Eagles RB Saquon Barkley is in a ‘funk.’ How can he break out of it?

Philadelphia Eagles running back Saquon Barkley (26) said he has "got to own it" after rushing for 22 yards on 10 carries in a loss to the Dallas Cowboys on Sunday. Kevin Jairaj / Imagn Images ...
NBC Sports

Saquon Barkley: I’ve had funks like this before, just need to break out of it

Eagles running back Saquon Barkley has failed to replicate his 2024 success this season and a bad year got even worse on Sunday. Barkley was limited to 22 yards on 10 carries and he lost a fumble in ...
Insider Monkey

Is Recursion Pharmaceuticals Inc. (RXRX) One of the Best Mid Cap Stocks to Buy According to Hedge Funds?

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best mid cap stocks to buy according to hedge funds. On November 1, TD Cowen analyst Brendan Smith touted the progress the company has made ...
STAT

Recursion’s incoming CEO: Beyond hype on AI-driven drug development, it’s time to show results

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...
Forbes

Recursion’s Incoming CEO Needs To Prove That AI Drug Development Can Pay Off

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
Bleacher Report

Predicting Every NFL Team's Biggest Breakout Player for Second Half of the Season

A lot can happen over the final eight weeks of the NFL season, and teams with playoff aspirations hope that includes a strong postseason push. However, even those clubs that are essentially out of the ...
STAT

Recursion CEO Chris Gibson out as company head after 12 years

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...